DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 115 filers reported holding DENALI THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $2,371,000 | +15.7% | 102,114 | +2.9% | 0.00% | 0.0% |
Q4 2018 | $2,050,000 | -49.1% | 99,212 | -46.5% | 0.00% | +50.0% |
Q3 2018 | $4,030,000 | +658.9% | 185,342 | +432.5% | 0.00% | +100.0% |
Q2 2018 | $531,000 | -10.2% | 34,808 | +16.0% | 0.00% | 0.0% |
Q1 2018 | $591,000 | – | 29,998 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 7,705,039 | $343,645,000 | 25.68% |
Casdin Capital, LLC | 1,500,000 | $66,900,000 | 1.89% |
Flagship Pioneering Inc. | 2,619,968 | $116,851,000 | 1.81% |
SECTORAL ASSET MANAGEMENT INC | 189,600 | $8,456,000 | 1.27% |
Integral Health Asset Management, LLC | 100,000 | $4,460,000 | 1.23% |
Temasek Holdings (Private) Ltd | 5,369,487 | $239,479,000 | 0.86% |
Goldstream Capital Management Ltd | 78,418 | $3,497,000 | 0.86% |
Yiheng Capital Management, L.P. | 335,184 | $14,949,000 | 0.76% |
GILDER GAGNON HOWE & CO LLC | 2,900,114 | $129,345,000 | 0.74% |
Artal Group S.A. | 600,000 | $26,760,000 | 0.73% |